MIR6762

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR6762 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR6762’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where MIR6762 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR6762 is over-expressed in tumor.

KIRP, THCA, and COAD are the cancer types where MIR6762 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6762 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
KIRPAllAll+0.183.0233view →
THCAAllAll+0.211.0352view →
COADFemaleAll+0.380.0281view →
LUADFemaleAll+0.211.0451view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

MIR6762–KIRP

Tumor-vs-normal expression box plot for MIR6762 RNA in KIRP.

Open the KIRP breakdown →

Exploration